Exhibitor Registration for 14th International Ultmann Chicago Lymphoma Symposium: Diagnosis and Management of Lymphoma

Chicago, IL US
May 5, 2017 to May 6, 2017
The 14th International Ultmann Chicago Lymphoma Symposium will focus upon the widespread and difficult challenges of understanding and controlling Hodgkin and non-Hodgkin lymphomas. Chicago is a city rich in academic tradition, and we welcome you to join us at the only dedicated lymphoma symposium in the Midwest. Given the current pace of increasing information and knowledge, there is an important need to discuss the growing body of data regarding the biology and treatment of patients with Hodgkin and non-Hodgkin lymphomas in a peer to peer format. Our stellar speakers’ list draws from local, national, and international expertise.

This symposium offers a tremendous opportunity to showcase your company products, services and achievements in front of a world stage of key decision makers and industry leaders. Increase your visibility and company profile by participating as an exhibitor at this exciting event.
 
The 14th Symposium is expected to attract over 200 leaders in the fields of medical oncology, radiation oncology, surgical oncology, fellows-in-training, oncology nurses, and allied health professionals committed to preventing, controlling, and eliminating lymphoma. This is an opportunity to market and showcase the broad range of products and services appropriate for Hodgkin and non-Hodgkin lymphomas.
Please visit our website at chicagolymphoma.com for more details pertaining to this year’s scientific program and invited speakers.
 
We hope you will join us along with our growing number of exhibitors in Chicago in 2017!

Target Audience

This activity has been designed for practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the other health professionals interested in the treatment and diagnosis of lymphoma.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Define new and novel treatment options for patients with chronic lymphocytic leukemia;
  • Identify new diagnostics and precision medicine platforms that can be utilized in the prognosis and treatment of lymphoma;
  • Discuss integration of checkpoint inhibitors in the treatment of lymphoma;
  • Evaluate treatment options for newly diagnosed and relapsed/refractory mantle cell lymphoma;
  • Compare varied treatment options for indolent follicular lymphoma;
  • Recognize the important prognostic factors and treatment targets in Waldenström’s macroglobulinemia;
  • Describe the current treatment options for patients with T-cell lymphoma.

 

Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
For more information, please contact:
CME Coordinator Contact Name: 
Sara Moellering
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
773-702-0018
Summary
Available credit: 
  • 8.50 AMA PRA Category 1 Credit™
  • 8.50 Participation
Event starts: 
05/05/2017 - 12:00pm
Event ends: 
05/06/2017 - 3:00pm
Activity opens: 
11/17/2016
Activity expires: 
11/06/2017
W Chicago City Center
172 West Adams St
Chicago, IL 60603
United States
SYMPOSIUM CO-CHAIRS
  Andrew M. Evens, DO, MSc
  Professor of Medicine and Chief
  Division of Hematology/Oncology
  Tufts University
  School of Medicine
  Director, Tufts Cancer Center
                          Tufts Medical Center
                          Boston, MA
 
  Sonali M. Smith, MD
  Associate Professor of Medicine
  Section of Hematology/Oncology
  Director, Lymphoma Program
  The University of Chicago
  Chicago, IL
 
  Barbara Pro, MD
  Professor of Medicine
  Division of Hematology/Oncology
  Northwestern University
  Feinberg School of Medicine
  Chicago, IL
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Credit Designation
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 8.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Nurses and other healthcare professionals will receive a Certificate of Participation.  For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Exhibit fee includes one six foot skirted table, two chairs, one wastebasket, one copy of the conference materials/syllabus and one symposium registration for admittance to all general sessions. For more information, download the exhibitor prospectus below.
 
EXHIBIT DISPLAY FEE
$2500

 
ADDITIONAL REGISTRATIONS
Early (Before April 4th): $400 per additional registrant
Regular (April 5 - May 4): $550 per additional registrant
Onsite (May 5 - 6): $600 per additional registrant

Please Note: You must log in to register. If you are not logged in,
you will see "Please login or create an account to take this course" in the red Summary box on your right.
If you have an account, click "login." If you don't have an account, click "create an account."

Once you have logged in, it will return you to this page.


APPLICATIONS The display fee is due on or before April 14, 2017. No company may exhibit unless payment for exhibit space has been received in full. Applications received after April 14, 2017 will be considered based on availability.


CANCELLATION POLICY All cancellations must be sent in writing. If written cancellation is received by April 14, 2017, exhibitors will receive a 50% refund. No refunds will be issued after April 14, 2017.


ADDITIONAL INFORMATION For general questions and additional information regarding exhibitor registration, please contact Sara Moellering via phone at 773-702-0018 or via email at smoellering@medicine.bsd.uchicago.edu.

Please login or create an account to proceed.